“Proprotein Convertase Subtilisin and Kexin Type 9 in Sub Clinical Hypothyroidism As a Risk Factor for Cardiovascular Disease”. Journal of Pharmaceutical Negative Results, vol. 13, no. 3, Oct. 2022, pp. 994-9, https://doi.org/10.47750/pnr.2022.13.03.155.